Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer

Clinical significance

Masaaki Iwatsuki, Koshi Mimori, Hideshi Lshii, Takehiko Yokobori, Yasushi Takatsuno, Tetsuya Sato, Hiroyuki Toh, Ichiro Onoyama, Keiichi Nakayama, Hideo Baba, Masaki Mori

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

This study focused on a cell cycle regulatory gene, FBXW7, which ubiquitinates c-Myc and cyclin E and promotes exit from the cell cycle. We determined the expression level of FBXW7 in colorectal cancer (CRC) cases, correlated those values with clinicopathologic features, and characterized the molecular mechanism of reduced expression of FBXW7 in CRC cells in vitro. FBXW7 mRNA and protein expression were evaluated in 93 CRC cases. Using CGH array, the copy number aberrations of the flanking region of FBXW7 were evaluated in another 130 CRC specimens. In vitro analysis of FBXW7 gene silencing in CRC cells was conducted. FBXW7 mRNA expression was significantly tower in tumor tissues than the corresponding normal tissues. The low FBXW7 expression group showed a significantly poorer prognosis than patients in the high expression group. A concordant relationship was observed between the incidence of KXIRH repression and the genetic alteration. The incidence of genetic alteration was associated with the stage of disease progression. In vitro, FBXW7-specific siRNA enhanced expression of c-MYC and cyclin E proteins and up-regulated cell proliferation. Genetic alterations in tumors led to the loss of FBXW7 expression and increased cell proliferation. FBXW7 expression provides a prognostic factor for patients with CRC.

Original languageEnglish
Pages (from-to)1828-1837
Number of pages10
JournalInternational Journal of Cancer
Volume126
Issue number8
DOIs
Publication statusPublished - Apr 15 2010

Fingerprint

cdc Genes
Colorectal Neoplasms
Cyclin E
Cell Proliferation
Messenger RNA
Incidence
Gene Silencing
Regulator Genes
Small Interfering RNA
Disease Progression
Neoplasms
Cell Cycle
Proteins
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer : Clinical significance. / Iwatsuki, Masaaki; Mimori, Koshi; Lshii, Hideshi; Yokobori, Takehiko; Takatsuno, Yasushi; Sato, Tetsuya; Toh, Hiroyuki; Onoyama, Ichiro; Nakayama, Keiichi; Baba, Hideo; Mori, Masaki.

In: International Journal of Cancer, Vol. 126, No. 8, 15.04.2010, p. 1828-1837.

Research output: Contribution to journalArticle

Iwatsuki, Masaaki ; Mimori, Koshi ; Lshii, Hideshi ; Yokobori, Takehiko ; Takatsuno, Yasushi ; Sato, Tetsuya ; Toh, Hiroyuki ; Onoyama, Ichiro ; Nakayama, Keiichi ; Baba, Hideo ; Mori, Masaki. / Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer : Clinical significance. In: International Journal of Cancer. 2010 ; Vol. 126, No. 8. pp. 1828-1837.
@article{628335c542a54507a245ba32b64a3d04,
title = "Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance",
abstract = "This study focused on a cell cycle regulatory gene, FBXW7, which ubiquitinates c-Myc and cyclin E and promotes exit from the cell cycle. We determined the expression level of FBXW7 in colorectal cancer (CRC) cases, correlated those values with clinicopathologic features, and characterized the molecular mechanism of reduced expression of FBXW7 in CRC cells in vitro. FBXW7 mRNA and protein expression were evaluated in 93 CRC cases. Using CGH array, the copy number aberrations of the flanking region of FBXW7 were evaluated in another 130 CRC specimens. In vitro analysis of FBXW7 gene silencing in CRC cells was conducted. FBXW7 mRNA expression was significantly tower in tumor tissues than the corresponding normal tissues. The low FBXW7 expression group showed a significantly poorer prognosis than patients in the high expression group. A concordant relationship was observed between the incidence of KXIRH repression and the genetic alteration. The incidence of genetic alteration was associated with the stage of disease progression. In vitro, FBXW7-specific siRNA enhanced expression of c-MYC and cyclin E proteins and up-regulated cell proliferation. Genetic alterations in tumors led to the loss of FBXW7 expression and increased cell proliferation. FBXW7 expression provides a prognostic factor for patients with CRC.",
author = "Masaaki Iwatsuki and Koshi Mimori and Hideshi Lshii and Takehiko Yokobori and Yasushi Takatsuno and Tetsuya Sato and Hiroyuki Toh and Ichiro Onoyama and Keiichi Nakayama and Hideo Baba and Masaki Mori",
year = "2010",
month = "4",
day = "15",
doi = "10.1002/ijc.24879",
language = "English",
volume = "126",
pages = "1828--1837",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer

T2 - Clinical significance

AU - Iwatsuki, Masaaki

AU - Mimori, Koshi

AU - Lshii, Hideshi

AU - Yokobori, Takehiko

AU - Takatsuno, Yasushi

AU - Sato, Tetsuya

AU - Toh, Hiroyuki

AU - Onoyama, Ichiro

AU - Nakayama, Keiichi

AU - Baba, Hideo

AU - Mori, Masaki

PY - 2010/4/15

Y1 - 2010/4/15

N2 - This study focused on a cell cycle regulatory gene, FBXW7, which ubiquitinates c-Myc and cyclin E and promotes exit from the cell cycle. We determined the expression level of FBXW7 in colorectal cancer (CRC) cases, correlated those values with clinicopathologic features, and characterized the molecular mechanism of reduced expression of FBXW7 in CRC cells in vitro. FBXW7 mRNA and protein expression were evaluated in 93 CRC cases. Using CGH array, the copy number aberrations of the flanking region of FBXW7 were evaluated in another 130 CRC specimens. In vitro analysis of FBXW7 gene silencing in CRC cells was conducted. FBXW7 mRNA expression was significantly tower in tumor tissues than the corresponding normal tissues. The low FBXW7 expression group showed a significantly poorer prognosis than patients in the high expression group. A concordant relationship was observed between the incidence of KXIRH repression and the genetic alteration. The incidence of genetic alteration was associated with the stage of disease progression. In vitro, FBXW7-specific siRNA enhanced expression of c-MYC and cyclin E proteins and up-regulated cell proliferation. Genetic alterations in tumors led to the loss of FBXW7 expression and increased cell proliferation. FBXW7 expression provides a prognostic factor for patients with CRC.

AB - This study focused on a cell cycle regulatory gene, FBXW7, which ubiquitinates c-Myc and cyclin E and promotes exit from the cell cycle. We determined the expression level of FBXW7 in colorectal cancer (CRC) cases, correlated those values with clinicopathologic features, and characterized the molecular mechanism of reduced expression of FBXW7 in CRC cells in vitro. FBXW7 mRNA and protein expression were evaluated in 93 CRC cases. Using CGH array, the copy number aberrations of the flanking region of FBXW7 were evaluated in another 130 CRC specimens. In vitro analysis of FBXW7 gene silencing in CRC cells was conducted. FBXW7 mRNA expression was significantly tower in tumor tissues than the corresponding normal tissues. The low FBXW7 expression group showed a significantly poorer prognosis than patients in the high expression group. A concordant relationship was observed between the incidence of KXIRH repression and the genetic alteration. The incidence of genetic alteration was associated with the stage of disease progression. In vitro, FBXW7-specific siRNA enhanced expression of c-MYC and cyclin E proteins and up-regulated cell proliferation. Genetic alterations in tumors led to the loss of FBXW7 expression and increased cell proliferation. FBXW7 expression provides a prognostic factor for patients with CRC.

UR - http://www.scopus.com/inward/record.url?scp=77949900799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949900799&partnerID=8YFLogxK

U2 - 10.1002/ijc.24879

DO - 10.1002/ijc.24879

M3 - Article

VL - 126

SP - 1828

EP - 1837

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -